State Bill Tracker

Across the country, states are introducing legislation to ensure access to non-opioid treatments and therapies. These policy efforts, often referred to as “pain parity” legislation, address the health insurance barriers many patients face when trying to access non-opioid treatment options.

The state legislative page includes introduced and passed legislation that ensures non-opioid pain treatments are not disadvantaged or discouraged for the treatment of pain relative to opioid treatments. Use the filters to learn more about state legislation.

2025 - Introduced

Virginia S.B.800

Ensures that no non-opioid approved by the FDA shall be disadvantaged or discouraged relative to opioids, including through prior authorization or step therapy.

Medicaid Parity

Read Bill

2024 - Introduced

Washington H.B.1034

Prohibits health insurers from imposing restrictive practices that disadvantage or discourage the use of non-opioid drugs for the treatment of pain relative to opioid drugs.

Medicaid Parity State Regulated Commercial Parity

Read Bill

2026 - Introduced

Washington S.B. 5916

Prohibits public and private health plans from disadvantaging non-opioid pain medications that are more restrictive or less favorable to the enrollee relative to the coverage of an opioid drug for the treatment or management of pain.
Requires the state to publish an educational pamphlet on non-opioid pain treatment alternatives.

Medicaid Parity State Employee Health Plan Parity Education

Read Senate Bill

2025 - Introduced

West Virginia H.B. 3070/S.B. 628

Prohibits West Virginia's Medicaid and commercial health insurance formularies or preferred drug lists from disadvantaging or discouraging a non-opioid drug with respect to coverage of an opioid drug, including through more restrictive coverage criteria, utilization management, or cost sharing.
Requires the West Virginia Bureau of Public Health develop educational materials about non-opioid alternatives for the treatment of acute pain.

Medicaid Parity State Regulated Commercial Parity

Read House Bill Read Senate Bill

2025 - Introduced

Wisconsin A.B. 499/S.B. 492

Requires health insurers to provide coverage for at least two FDA-approved non-opioid prescription medication treatment options and three alternative nonpharmacological treatment modalities.
Prohibits utilization controls that are more restrictive or extensive than the least restrictive or extensive utilization controls for opioids.
Requires health insurers to provide information about the pain management access plan to enrollees and health care providers and to make the plan available on its website.

State Regulated Commercial Parity

Read House Bill Read Senate Bill